American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease - PubMed (original) (raw)
Review
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
Gary R Lichtenstein et al. Gastroenterology. 2006 Mar.
No abstract available
Similar articles
- American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association. Lichtenstein GR, et al. Gastroenterology. 2006 Mar;130(3):935-9. doi: 10.1053/j.gastro.2006.01.047. Gastroenterology. 2006. PMID: 16530531 No abstract available. - [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W. Lichtenstein GR, et al. Rev Gastroenterol Mex. 2006 Jul-Sep;71(3):351-401. Rev Gastroenterol Mex. 2006. PMID: 17140062 Review. Spanish. No abstract available. - Pharmacogenetics of inflammatory bowel disease.
Katsanos KH, Papadakis KA. Katsanos KH, et al. Pharmacogenomics. 2014 Dec;15(16):2049-62. doi: 10.2217/pgs.14.154. Pharmacogenomics. 2014. PMID: 25521361 Review. - [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Rogler G. Rogler G. Dtsch Med Wochenschr. 2008 Sep;133(38):1917-21. doi: 10.1055/s-0028-1085577. Epub 2008 Sep 10. Dtsch Med Wochenschr. 2008. PMID: 18785084 Review. German. No abstract available. - [Crohn's disease--standards of treatment 2004].
Kruis W. Kruis W. Praxis (Bern 1994). 2005 Oct 12;94(41):1595-8. doi: 10.1024/0369-8394.94.41.1595. Praxis (Bern 1994). 2005. PMID: 16245637 Review. German.
Cited by
- Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study.
Fischer A, Mac S, Freiman ES, Marshall JK, Rand K, Ramos-Goñi JM. Fischer A, et al. Pharmacoecon Open. 2024 Oct 8. doi: 10.1007/s41669-024-00523-5. Online ahead of print. Pharmacoecon Open. 2024. PMID: 39377864 - How Do Polyphenol-Rich Foods Prevent Oxidative Stress and Maintain Gut Health?
Jawhara S. Jawhara S. Microorganisms. 2024 Jul 31;12(8):1570. doi: 10.3390/microorganisms12081570. Microorganisms. 2024. PMID: 39203412 Free PMC article. Review. - The Effectiveness of Measuring Thiopurine Metabolites in the Treatment of Autoimmune Hepatitis Patients.
Yassin W, Nasser R, Veitsman E, Saadi T. Yassin W, et al. Turk J Gastroenterol. 2024 Jan 17;35(3):232-238. doi: 10.5152/tjg.2024.22838. Turk J Gastroenterol. 2024. PMID: 39115109 Free PMC article. - Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions.
Zaid Alkilani A, Omar S, Nasereddin J, Hamed R, Obeidat R. Zaid Alkilani A, et al. Heliyon. 2024 Jul 6;10(14):e34212. doi: 10.1016/j.heliyon.2024.e34212. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39100451 Free PMC article. - Comparison of outcomes in small bowel surgery for Crohn's disease: a retrospective NSQIP review.
Aras OA, Patel AS, Satchell EK, Serniak NJ, Byrne RM, Cagir B. Aras OA, et al. Int J Colorectal Dis. 2024 Jul 29;39(1):119. doi: 10.1007/s00384-024-04661-4. Int J Colorectal Dis. 2024. PMID: 39073495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical